BSD Medical Announces Purchase of BSD-500 Hyperthermia System

BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”) announced that the John Stoddard Cancer Center (Stoddard Cancer Center) at Iowa Methodist Medical Center has purchased a BSD-500 Hyperthermia System (BSD-500).

Stoddard Cancer Center (http://www.johnstoddardcancer.org) is one of the most technologically advanced and diverse radiation oncology departments in the Midwest. In 1962, Iowa Methodist Medical Center established Iowa's first hospital-based radiation oncology department and remains a leader in providing healthcare services in the Midwest. Stoddard Cancer Center, which opened in 1991 at Iowa Methodist Medical Center, was the first cancer center in central Iowa to house all radiation oncology and ancillary services in one location, thus providing the most advanced therapeutic resources in cancer treatment.

The high standard of care at Stoddard is a result of decades of research, cancer treatment experience, and technological superiority. The Stoddard Cancer Center's philosophy of family-centered care allows the hospital to provide modern, state-of-the-art, treatment technology in an atmosphere that reflects the importance of having family and friends involved in the treatment process.

“Clinical studies have shown that hyperthermia delivered using the BSD-500 can significantly increase the effectiveness of radiation therapy without a significant increase in toxicity for certain tumors. We are excited to have a BSD hyperthermia system placed in the prestigious Stoddard Cancer Center," stated Harold Wolcott, BSD's president.
(4.17.12)